Literature DB >> 15305961

Enhanced specificity of a dual chamber ICD arrhythmia detection algorithm by rate stability criteria.

Ralph Mletzko1, Frederic Anselme, Didier Klug, Wolfgang Schoels, Robert Bowes, Nicolas Iscolo, Rémi Nitzsché, Nicolas Sadoul.   

Abstract

Inappropriate therapy remains an important limitation of implantable cardioverter defibrillators (ICD). PARAD+ was developed to increase the specificity conferred by the original PARAD detection algorithm in the detection of atrial fibrillation (AF). To compare the performances of the two different algorithms, we retrospectively analyzed all spontaneous and sustained episodes of AF and ventricular tachycardia (VT) documented by state-of-the-art ICDs programmed with PARAD or PARAD+ at the physicians' discretion. The results were stratified according to tachycardia rates <150 versus > or =150 beats/min. The study included 329 men and 48 women (64 +/- 10 years of age). PARAD was programmed in 263, and PARAD+ in 84 devices. During a mean follow-up of 11 +/- 3 months, 1,019 VT and 315 AF episodes were documented among 338 devices. For tachycardias with ventricular rates <150 beats/min, the sensitivity of PARAD versus PARAD+ was 96% versus 99% (NS), specificity 80% versus 93% (P < 0.002), positive predictive value (PPV) 94% versus 91% (NS), and negative predictive value (NPV) 86% versus 99% (P < 0.0001). In contrast, in the fast VT zone, the specificity and PPV of PARAD (95% versus 84% and 100% versus 96%) were higher than those of PARAD+ (NS, P < 0.001). Among 23 AF episodes treated in 16 patients, 3 episodes triggered an inappropriate shock in 3 patients, all in the PARAD population. PARAD+ significantly increased the ICD algorithm diagnostic specificity and NPV for AF in the slow VT zone without compromising patient safety.

Entities:  

Mesh:

Year:  2004        PMID: 15305961     DOI: 10.1111/j.1540-8159.2004.00593.x

Source DB:  PubMed          Journal:  Pacing Clin Electrophysiol        ISSN: 0147-8389            Impact factor:   1.976


  1 in total

1.  Does the rate of inappropriate therapy differ in implantable cardioverter-defibrillators from different manufacturers?

Authors:  Arash Arya; Majid Haghjoo; Zahra Emkanjoo; Mohammad Reza Dehghani; Mohammad Ali Sadr-Ameli
Journal:  J Interv Card Electrophysiol       Date:  2007-01-17       Impact factor: 1.900

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.